TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,480 | -99.5% | 15,847 | -98.4% | 0.00% | -100.0% |
| Q2 2023 | $24,259,143 | +1922.6% | 976,615 | +1124.6% | 0.04% | +1850.0% |
| Q1 2023 | $1,199,409 | +1469.2% | 79,748 | +1134.3% | 0.00% | – |
| Q4 2022 | $76,433 | +96.0% | 6,461 | -2.2% | 0.00% | – |
| Q3 2022 | $39,000 | +875.0% | 6,603 | +517.1% | 0.00% | – |
| Q2 2022 | $4,000 | -98.1% | 1,070 | -95.2% | 0.00% | – |
| Q1 2022 | $213,000 | -52.9% | 22,411 | -5.8% | 0.00% | -100.0% |
| Q4 2021 | $452,000 | – | 23,792 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 1,647,000 | $6,423,000 | 0.45% |
| DAFNA Capital Management LLC | 75,000 | $293,000 | 0.30% |
| Baker Brothers Advisors | 2,199,656 | $8,579,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 71,105 | $277,000 | 0.05% |
| SMITH ASSET MANAGEMENT GROUP LP | 196,684 | $767,000 | 0.03% |
| SABBY MANAGEMENT, LLC | 66,000 | $257,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 1,000 | $4,000 | 0.01% |
| COLUMBUS CIRCLE INVESTORS | 161,919 | $631,000 | 0.00% |
| JENNISON ASSOCIATES LLC | 455,271 | $1,776,000 | 0.00% |
| BlackRock Fund Advisors | 448,445 | $1,749,000 | 0.00% |